Team:Paris Bettencourt/Achievements
From 2012.igem.org
(→Achievements of all the different modules) |
|||
Line 54: | Line 54: | ||
</table> | </table> | ||
- | + | ==Human Practice== | |
- | + | <table id="tableboxed"> | |
+ | <tr> | ||
+ | <td> | ||
+ | test | ||
+ | </td> | ||
+ | </tr> | ||
+ | </table> | ||
<!-- ########## Don't edit below ########## --> | <!-- ########## Don't edit below ########## --> | ||
{{:Team:Paris_Bettencourt/footer}} | {{:Team:Paris_Bettencourt/footer}} |
Revision as of 01:17, 27 September 2012
Achievements of all the different modules
Achievements : Semantic containment
The first part (supD) is well characterized and works well. For the second parts, it turns out that this mutation is quite leaky, although it works in lab conditions, one mutation is not enough if we want to release such parts in nature. Other reasons emphasize this observation, notably the weakness of being at one mutation to recover the protein functionality.
Resctriction enzyme system
Suicide system We showed that Colicin E2 cells induce cell death in sensitive populations, and that these sensitive populations can be protected by providing them with our engineered immunity protein.
Part K914001 is well characterized and provides immunity to sensitive cells against the Colicin E2 activity protein, but is leaky. Part K914002 is promoterless and allows users to easily plug in the appropriate promoter for their desired purpose.
MAGE
Synthetic Import Domain
|
Human Practice
test |